Clinical Trials Directory

Trials / Completed

CompletedNCT05710874

A Prospective, Randomized, Clinical Study on the Effects of CPP-ACP-paste, Fluoride and a Combination on the Evolution of White Spot Lesions in Orthodontic Patients After Debonding.

A Prospective, Randomized, Clinical Study on the Effects of Casein Phosphopeptide Amorphous Calcium Phosphate Paste, Fluoride and a Combination on the Evolution of White Spot Lesions in Orthodontic Patients After Debonding.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
107 (actual)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
All
Age
12 Years – 60 Years
Healthy volunteers
Accepted

Summary

The goal of this randomized clinical trial is to compare the influence of casein phosphopeptide amorphous calcium phosphate (CPP-ACP), CPP-ACP in combination with fluoride (CPP-ACPF), high fluoride concentration, and conventional fluoride toothpaste on the color and size of white spot lesions (WSLs) in orthodontic patients following bracket removal.

Conditions

Interventions

TypeNameDescription
OTHERCPP-ACP pasteDaily application of CPP-ACP (Casein phosphopeptide amorphous calcium phosphate) paste (Tooth Mousse®) in addition to twice daily use of conventional toothpaste.
OTHERCPP-ACPF pasteDaily application of CPP-ACPF (Casein phosphopeptide amorphous calcium phosphate in combination with fluoridepaste) (MI Paste Plus®) in addition to twice daily use of conventional toothpaste.
OTHER1.25% fluoride gelWeekly application of 1.25% fluoride gel (Elmex Medical Gel®) in addition to twice daily use of conventional toothpaste.
OTHERConventionalTwice daily use of conventional toothpaste.

Timeline

Start date
2016-09-23
Primary completion
2023-03-29
Completion
2023-03-29
First posted
2023-02-02
Last updated
2023-08-24

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05710874. Inclusion in this directory is not an endorsement.